Product Images Rizatriptan Benzoate

This appears to be a label of a medication called "Rizatriptan". It comes in a pink, round tablet form with a strength of 10mg as a blister pack. The recommended storage temperature is 20°-25°C (68°-77°F) at room temperature. The label also provides details such as its National Drug Code (NDC) number of 7133519121 and an expiration date. Patients are advised to store it in a safe place out of reach of children.*

Figure 1 displays the probability of achieving an initial headache response in a pooled study of four placebo-controlled outpatient trials using Rizatriptan Benzoate. The graph shows estimated probabilities in percentages ranging from 100% to 0% on the Y-axis at various hours post-dose on the X-axis. The different estimated response rates are based on the dosage of the medication. The averages were obtained by pooling data from the four trials. The Kaplan-Meier plot is used to show the rate of obtaining headache response (no or mild pain) with Rizatriptan Benzoate or placebo over time. The study only included patients who responded to treatment within two hours.*

The Figure 2 graph shows the percentage of patients who took a second dose of Rizatriptan Benzoate tablets or other medication for migraines over a 24 hour period following the initial dose. The data displayed was obtained from four placebo-controlled outpatient clinical studies, and includes both patients who had a headache response at 2 hours and those who did not. Remedication was not allowed within 2 hours of the initial dose.*

The text represents a graph or chart labeled "Figure5" that shows the percentage (with a 95% confidence interval) of patients reporting no headache pain by 2 hours after taking medication. The observed percentage is plotted for both Rizatriptan Benzoate Orally Disintegrating Tablets and placebo. The x-axis extends up to 20 hours after the stage 2 dose, with data points plotted at 5-hour intervals.*